Always consult with a licensed healthcare provider to determine whether Semaglutide is right for you
For patients who may not have achieved optimal results with dual agonists, or those with unique comorbidities like advanced non-alcoholic fatty liver disease (NAFLD), the introduction of Retatrutide is not just an incremental improvement, it is a re-evaluation of treatment goals
Zheng J, Liu G, Tozkoparan B, Wen D
WEIGHT LOSS MEDICATIONS Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors
While compounded tirzepatide should work similarly to Zepbound, it hasnt undergone FDA-testing and may have added ingredients
Contact your GP or prescribing clinician promptly to discuss your symptoms